Details about Neeraj Sood

Access statistics for papers by Neeraj Sood.

Last updated 2022-11-06. Update your information in the RePEc Author Service.

Short-id: pso62

Working Papers

2022

1. The Ex-Ante Moral Hazard Effects of COVID-19 Vaccines
   NBER Working Papers, National Bureau of Economic Research, Inc
2. The Impact of Direct-to-Consumer Advertising on Outpatient Care Utilization
   NBER Working Papers, National Bureau of Economic Research, Inc

2021

3. Back to School: The Effect of School Visits During COVID-19 on COVID-19 Transmission
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (12)
4. The Impact of the COVID-19 Pandemic and Policy Responses on Excess Mortality
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (3)
5. The Impact of the COVID-19 Vaccine Distribution on Mental Health Outcomes
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (3)

2020

6. The Impact of the COVID-19 Pandemic and Policy Response on Health Care Utilization: Evidence from County-level Medical Claims and Cellphone data
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (6)

2019

7. Does The Market Reward Quality?: Evidence from India
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (1)

2016

8. Financial Risk Protection from Social Health Insurance
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (2)
   See also Journal Article in Journal of Health Economics (2017)

2015

9. Do “Consumer-Directed” Health Plans Bend the Cost Curve Over Time?
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (5)
   See also Journal Article in Journal of Health Economics (2016)
10. Effects of Payment Reform in More versus Less Competitive Markets
    NBER Working Papers, National Bureau of Economic Research, Inc
    See also Journal Article in Journal of Health Economics (2017)
11. Patient Responses to Incentives in Consumer-directed Health Plans: Evidence from Pharmaceuticals
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (8)
12. Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (8)

2013

13. Conforming and Non-conforming Peer Effects in Vaccination Decisions
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (6)
14. Identifying the Health Production Function: The Case of Hospitals
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (6)
15. The Impact of Insurance and HIV Treatment Technology on HIV Testing
    NBER Working Papers, National Bureau of Economic Research, Inc

2012

16. Effects of Medicare Payment Reform: Evidence from the Home Health Interim and Prospective Payment Systems
    Scholarly Articles, Harvard Kennedy School of Government
    Also in NBER Working Papers, National Bureau of Economic Research, Inc (2012)
    Working Paper Series, Harvard University, John F. Kennedy School of Government (2012) View citations (1)
    See also Journal Article in Journal of Health Economics (2014)

2011

17. The Effect of Prospective Payment on Admission and Treatment Policy: Evidence from Inpatient Rehabilitation Facilities
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (4)
    See also Journal Article in Journal of Health Economics (2013)

2010

18. Health and Access Effects of New Drugs: Combining Experimental and Non-Experimental Data
    Cahiers de recherche, CIRPEE

2009

19. Does Health Insurance Make You Fat?
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (17)
    See also Chapter (2011)
20. Federal Life Sciences Funding and University R&D
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (13)

2008

21. The Impact of Medicare Part D on Pharmaceutical R&D
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (9)

2007

22. Criminal Prosecution and HIV-related Risky Behavior
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (2)
23. Mortality Risks, Health Endowments, and Parental Investments in Infancy: Evidence from Rural India
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (5)
24. The Welfare Effects of Public Drug Insurance
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (20)

2006

25. Does How Much and How You Pay Matter? Evidence from the Inpatient Rehabilitation Facility Prospective Payment System
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (1)
26. Health Insurance as a Two-Part Pricing Contract
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (15)
    See also Journal Article in Journal of Public Economics (2013)

2005

27. Health Insurance and the Obesity Externality
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (31)
28. Insurance and Innovation in Health Care Markets
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (6)
29. Technology, Monopoly, and the Decline of the Viatical Settlements Industry
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (1)
30. Wage and Benefit Changes in Response to Rising Health Insurance Costs
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (6)

2004

31. HIV Breakthroughs and Risk Sexual Behavior
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (17)
    See also Journal Article in The Quarterly Journal of Economics (2006)

2003

32. Market Evidence of Misperceived Prices and Mistaken Mortality Risks
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (5)
33. The Reallocation of Compensation in Response to Health Insurance Premium Increases
    NBER Working Papers, National Bureau of Economic Research, Inc
    See also Journal Article in Economics Letters (2005)

2002

34. The Link Between Public and Private Insurance and HIV-Related Mortality
    NBER Working Papers, National Bureau of Economic Research, Inc
    See also Journal Article in Journal of Health Economics (2003)

Undated

35. Employer-Sponsored Insurance, Health Care Cost Growth, and the Economic Performance of U.S. Industries
    Mathematica Policy Research Reports, Mathematica Policy Research View citations (1)

Journal Articles

2021

1. Do companies in the pharmaceutical supply chain earn excess returns?
   International Journal of Health Economics and Management, 2021, 21, (1), 99-114 View citations (1)
2. Effects of employer-offered high-deductible plans on low-value spending in the privately insured population
   Journal of Health Economics, 2021, 76, (C) View citations (1)

2019

3. Productivity growth of skilled nursing facilities in the treatment of post-acute-care-intensive conditions
   PLOS ONE, 2019, 14, (4), 1-14

2018

4. Do Physicians Respond to the Costs and Cost-Sensitivity of Their Patients?
   American Economic Journal: Economic Policy, 2018, 10, (1), 113-52 View citations (16)
5. Government health insurance and spatial peer effects: New evidence from India
   Social Science & Medicine, 2018, 196, (C), 131-141 View citations (3)

2017

6. Effects of payment reform in more versus less competitive markets
   Journal of Health Economics, 2017, 51, (C), 66-83 View citations (1)
   See also Working Paper (2015)
7. Financial risk protection from social health insurance
   Journal of Health Economics, 2017, 55, (C), 14-29 View citations (10)
   See also Working Paper (2016)
8. The long term effects of “Consumer-Directed” health plans on preventive care use
   Journal of Health Economics, 2017, 55, (C), 61-75 View citations (1)

2016

9. Do “Consumer-Directed” health plans bend the cost curve over time?
   Journal of Health Economics, 2016, 46, (C), 33-51 View citations (10)
   See also Working Paper (2015)
10. WHY MEDICARE PRICE NEGOTIATION IS THE WRONG PRESCRIPTION FOR RISING DRUG SPENDING
    Journal of Policy Analysis and Management, 2016, 35, (4), 956-963
11. WHY MEDICARE PRICE NEGOTIATION IS THE WRONG PRESCRIPTION FOR RISING DRUG SPENDING: RESPONSE TO RENA CONTI
    Journal of Policy Analysis and Management, 2016, 35, (4), 970-972

2015

12. Do Statins Reduce the Health and Health Care Costs of Obesity?
    PharmacoEconomics, 2015, 33, (7), 723-734 View citations (4)
13. The Impact of Insurance on HIV Testing
    American Journal of Health Economics, 2015, 1, (4), 515-536 View citations (2)
    Also in American Journal of Health Economics, 2015, 1, (4), 515-536 (2015) View citations (2)
14. The effect of federal research funding on formation of university-firm biopharmaceutical alliances
    The Journal of Technology Transfer, 2015, 40, (5), 859-876 View citations (4)
15. University R&D Funding Strategies in a Changing Federal Funding Environment
    Science and Public Policy, 2015, 42, (3), 355-368 View citations (6)

2014

16. Effects of Medicare payment reform: Evidence from the home health interim and prospective payment systems
    Journal of Health Economics, 2014, 34, (C), 1-18 View citations (13)
    See also Working Paper (2012)
17. HIV-related social intolerance and risky sexual behavior in a high HIV prevalence environment
    Social Science & Medicine, 2014, 111, (C), 84-93 View citations (1)

2013

18. Health insurance as a two-part pricing contract
    Journal of Public Economics, 2013, 102, (C), 1-12 View citations (31)
    See also Working Paper (2006)
19. Market size and innovation: Effects of Medicare Part D on pharmaceutical research and development
    Journal of Public Economics, 2013, 97, (C), 327-336 View citations (67)
20. Pharmaceutical advertising and Medicare Part D
    Journal of Health Economics, 2013, 32, (6), 1356-1367 View citations (21)
21. Price Shopping in Consumer-Directed Health Plans
    Forum for Health Economics & Policy, 2013, 16, (1), 19 View citations (6)
22. Quantifying the Value of Personalized Medicines: Evidence from COX-2 Inhibitors
    Forum for Health Economics & Policy, 2013, 16, (1), 22 View citations (2)
23. The Value of Diagnostic Testing in Personalized Medicine
    Forum for Health Economics & Policy, 2013, 16, (2), 121-133 View citations (3)
24. The effect of prospective payment on admission and treatment policy: Evidence from inpatient rehabilitation facilities
    Journal of Health Economics, 2013, 32, (5), 965-979 View citations (9)
    See also Working Paper (2011)

2012

25. Healthy Firms: Constraints to Growth among Private Health Sector Facilities in Ghana and Kenya
    PLOS ONE, 2012, 7, (2), 1-9 View citations (1)

2011

26. Do People Taking Flu Vaccines Need Them the Most?
    PLOS ONE, 2011, 6, (12), 1-8
27. Firm-Level Perspectives on Public Sector Engagement with Private Healthcare Providers: Survey Evidence from Ghana and Kenya
    PLOS ONE, 2011, 6, (11), 1-12 View citations (2)
28. How Do Consumer-Directed Health Plans Affect Vulnerable Populations?
    Forum for Health Economics & Policy, 2011, 14, (2), 1-25 View citations (7)
29. The Effects of Consumer-Directed Health Plans on Episodes of Health Care
    Forum for Health Economics & Policy, 2011, 14, (2), 1-28 View citations (1)
30. Who Pays for Obesity?
    Journal of Economic Perspectives, 2011, 25, (1), 139-58 View citations (77)

2010

31. Criminal Prosecution and Human Immunodeficiency Virus-Related Risky Behavior
    Journal of Law and Economics, 2010, 53, (4), 741 - 782 View citations (1)
32. Private Sector Participation and Health System Performance in Sub-Saharan Africa
    PLOS ONE, 2010, 5, (10), 1-9 View citations (5)

2009

33. Innovation and the welfare effects of public drug insurance
    Journal of Public Economics, 2009, 93, (3-4), 541-548 View citations (35)
34. Market evidence of misperceived mortality risk
    Journal of Economic Behavior & Organization, 2009, 72, (1), 451-462 View citations (4)

2008

35. Does how much and how you pay matter? Evidence from the inpatient rehabilitation care prospective payment system
    Journal of Health Economics, 2008, 27, (4), 1046-1059 View citations (17)

2007

36. Market power and state costs of HIV/AIDS drugs
    International Journal of Health Economics and Management, 2007, 7, (1), 59-71 View citations (1)
37. The Effect of State Cost Containment Strategies on the Insurance Status and Use of Antiretroviral Therapy (HAART) for HIV Infected People
    Forum for Health Economics & Policy, 2007, 10, (2), 1-23
38. The Short and Long Run Effects of Daylight Saving Time on Fatal Automobile Crashes
    The B.E. Journal of Economic Analysis & Policy, 2007, 7, (1), 1-22 View citations (15)

2006

39. Adverse Selection in Retiree Prescription Drug Plans
    Forum for Health Economics & Policy, 2006, 9, (1), 1-25 View citations (4)
    See also Chapter (2006)
40. HIV Breakthroughs and Risky Sexual Behavior
    The Quarterly Journal of Economics, 2006, 121, (3), 1063-1102 View citations (59)
    See also Working Paper (2004)

2005

41. The reallocation of compensation in response to health insurance premium increases
    Economics Letters, 2005, 88, (2), 147-151 View citations (3)
    See also Working Paper (2003)
42. Wage and Benefit Changes in Response to Rising Health Insurance
    Forum for Health Economics & Policy, 2005, 8, (1), 1-17 View citations (6)
    See also Chapter (2005)

2004

43. New Evidence on Hospital Profitability by Payer Group and the Effects of Payer Generosity
    International Journal of Health Economics and Management, 2004, 4, (3), 231-246 View citations (5)
44. Price Regulation in Secondary Insurance Markets
    Journal of Risk & Insurance, 2004, 71, (4), 643-675 View citations (6)
45. Social insurance and the design of innovation incentives
    Economics Letters, 2004, 85, (1), 57-61 View citations (45)

2003

46. The link between public and private insurance and HIV-related mortality
    Journal of Health Economics, 2003, 22, (6), 1105-1122 View citations (24)
    See also Working Paper (2002)

2002

47. Optimal contributions to flexible spending accounts
    Economics Letters, 2002, 76, (1), 129-135 View citations (1)

Chapters

2020

1. Quantifying Productivity Growth in the Delivery of Important Episodes of Care within the Medicare Program Using Insurance Claims and Administrative Data
   A chapter in Big Data for Twenty-First-Century Economic Statistics, 2020, pp 297-338 View citations (1)

2011

2. Does Health Insurance Make You Fat?
   A chapter in Economic Aspects of Obesity, 2011, pp 35-64 View citations (17)
   See also Working Paper (2009)

2006

3. Adverse Selection in Retiree Prescription Drug Plans
   A chapter in Frontiers in Health Policy Research, Volume 9, 2006 View citations (3)
   See also Journal Article in Forum for Health Economics & Policy (2006)

2005

4. Wage and Benefit Changes in Response to Rising Health Insurance
   A chapter in Frontiers in Health Policy Research, Volume 8, 2005 View citations (6)
   See also Journal Article in Forum for Health Economics & Policy (2005)